 Jason Burdick
Concepts (727)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 126 | 2023 | 582 | 28.470 |
Why?
| | Hyaluronic Acid | 72 | 2022 | 197 | 15.730 |
Why?
| | Biocompatible Materials | 79 | 2023 | 378 | 14.730 |
Why?
| | Tissue Engineering | 75 | 2023 | 362 | 13.410 |
Why?
| | Polymers | 41 | 2022 | 482 | 7.420 |
Why?
| | Tissue Scaffolds | 36 | 2023 | 184 | 7.140 |
Why?
| | Bioprinting | 11 | 2023 | 19 | 6.690 |
Why?
| | Printing, Three-Dimensional | 17 | 2023 | 63 | 5.910 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 18 | 2017 | 74 | 5.380 |
Why?
| | Chondrogenesis | 23 | 2023 | 79 | 5.220 |
Why?
| | Myocardial Infarction | 34 | 2023 | 968 | 4.090 |
Why?
| | Extracellular Matrix | 27 | 2023 | 446 | 3.910 |
Why?
| | Cartilage | 14 | 2019 | 183 | 3.290 |
Why?
| | Cross-Linking Reagents | 22 | 2021 | 186 | 3.010 |
Why?
| | Ventricular Remodeling | 20 | 2023 | 229 | 2.980 |
Why?
| | Delayed-Action Preparations | 13 | 2018 | 161 | 2.920 |
Why?
| | Myocardium | 20 | 2023 | 970 | 2.830 |
Why?
| | Nanotubes | 9 | 2016 | 41 | 2.670 |
Why?
| | Mechanotransduction, Cellular | 11 | 2023 | 101 | 2.610 |
Why?
| | Biomimetic Materials | 6 | 2018 | 66 | 2.610 |
Why?
| | Drug Carriers | 9 | 2018 | 119 | 2.600 |
Why?
| | Cell Culture Techniques | 13 | 2021 | 356 | 2.520 |
Why?
| | Nanofibers | 8 | 2021 | 21 | 2.470 |
Why?
| | Animals | 147 | 2023 | 33381 | 2.350 |
Why?
| | Light | 14 | 2018 | 342 | 2.330 |
Why?
| | Materials Testing | 23 | 2021 | 359 | 2.300 |
Why?
| | Stem Cells | 15 | 2020 | 559 | 2.280 |
Why?
| | Chondrocytes | 11 | 2021 | 206 | 2.130 |
Why?
| | Drug Delivery Systems | 16 | 2021 | 306 | 2.060 |
Why?
| | Cartilage, Articular | 9 | 2021 | 306 | 2.060 |
Why?
| | Cell Adhesion | 22 | 2022 | 443 | 2.030 |
Why?
| | Injections | 20 | 2019 | 167 | 1.910 |
Why?
| | Regeneration | 10 | 2019 | 165 | 1.810 |
Why?
| | Meniscus | 3 | 2023 | 22 | 1.740 |
Why?
| | Cell Movement | 13 | 2019 | 896 | 1.680 |
Why?
| | beta-Cyclodextrins | 7 | 2019 | 31 | 1.670 |
Why?
| | Osteogenesis | 7 | 2021 | 213 | 1.640 |
Why?
| | Cadherins | 4 | 2018 | 186 | 1.630 |
Why?
| | Adhesives | 3 | 2022 | 11 | 1.620 |
Why?
| | Hepatic Stellate Cells | 3 | 2016 | 10 | 1.610 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 564 | 1.540 |
Why?
| | Cell Differentiation | 20 | 2023 | 1753 | 1.510 |
Why?
| | Cells, Cultured | 37 | 2023 | 4077 | 1.500 |
Why?
| | Stem Cell Transplantation | 5 | 2018 | 153 | 1.500 |
Why?
| | Absorbable Implants | 8 | 2015 | 35 | 1.500 |
Why?
| | Microspheres | 12 | 2014 | 130 | 1.490 |
Why?
| | Combinatorial Chemistry Techniques | 4 | 2018 | 18 | 1.450 |
Why?
| | Mechanical Phenomena | 8 | 2018 | 86 | 1.430 |
Why?
| | Cellular Microenvironment | 6 | 2022 | 79 | 1.390 |
Why?
| | Antigens, CD | 3 | 2018 | 460 | 1.370 |
Why?
| | Glycerol | 4 | 2016 | 88 | 1.320 |
Why?
| | Ventricular Function, Left | 14 | 2023 | 468 | 1.290 |
Why?
| | Peptides | 7 | 2018 | 879 | 1.290 |
Why?
| | Biomedical Technology | 3 | 2020 | 43 | 1.270 |
Why?
| | Polyethylene Glycols | 17 | 2023 | 578 | 1.250 |
Why?
| | Elastomers | 5 | 2016 | 29 | 1.250 |
Why?
| | Cell Lineage | 4 | 2021 | 318 | 1.240 |
Why?
| | Rheology | 11 | 2022 | 87 | 1.230 |
Why?
| | Osteoblasts | 7 | 2008 | 115 | 1.220 |
Why?
| | Swine | 19 | 2023 | 730 | 1.170 |
Why?
| | Cell Survival | 19 | 2018 | 1047 | 1.160 |
Why?
| | Myofibroblasts | 5 | 2021 | 120 | 1.140 |
Why?
| | Rats | 33 | 2023 | 5392 | 1.120 |
Why?
| | Transforming Growth Factor beta3 | 4 | 2021 | 9 | 1.120 |
Why?
| | Infrared Rays | 4 | 2016 | 23 | 1.110 |
Why?
| | Chemokine CXCL12 | 4 | 2021 | 80 | 1.110 |
Why?
| | NIH 3T3 Cells | 10 | 2018 | 139 | 1.100 |
Why?
| | Porosity | 9 | 2022 | 93 | 1.080 |
Why?
| | Bone Morphogenetic Protein 2 | 3 | 2015 | 90 | 1.070 |
Why?
| | Dimethylpolysiloxanes | 2 | 2017 | 9 | 1.070 |
Why?
| | Mice | 42 | 2023 | 15520 | 1.050 |
Why?
| | Endothelial Cells | 6 | 2023 | 732 | 1.030 |
Why?
| | Photochemical Processes | 6 | 2020 | 98 | 1.020 |
Why?
| | Methacrylates | 8 | 2016 | 110 | 1.020 |
Why?
| | Humans | 129 | 2023 | 118974 | 1.010 |
Why?
| | Biopolymers | 3 | 2020 | 26 | 0.990 |
Why?
| | Regenerative Medicine | 5 | 2018 | 46 | 0.970 |
Why?
| | Guided Tissue Regeneration | 6 | 2015 | 14 | 0.940 |
Why?
| | Interleukin-10 | 5 | 2018 | 306 | 0.940 |
Why?
| | Adamantane | 5 | 2021 | 16 | 0.930 |
Why?
| | Collagen | 8 | 2019 | 433 | 0.920 |
Why?
| | Esters | 4 | 2022 | 61 | 0.920 |
Why?
| | Elastic Modulus | 12 | 2019 | 118 | 0.910 |
Why?
| | Signal Transduction | 10 | 2023 | 4709 | 0.910 |
Why?
| | Hyaluronan Receptors | 3 | 2019 | 93 | 0.890 |
Why?
| | Rats, Sprague-Dawley | 17 | 2017 | 2478 | 0.860 |
Why?
| | Nanotechnology | 3 | 2014 | 120 | 0.840 |
Why?
| | Endothelial Progenitor Cells | 5 | 2021 | 18 | 0.830 |
Why?
| | Heart Ventricles | 8 | 2022 | 727 | 0.830 |
Why?
| | Oligopeptides | 5 | 2019 | 252 | 0.810 |
Why?
| | Neovascularization, Physiologic | 10 | 2019 | 181 | 0.800 |
Why?
| | Decanoates | 3 | 2010 | 4 | 0.790 |
Why?
| | Fractures, Cartilage | 3 | 2015 | 5 | 0.790 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 3 | 2018 | 7 | 0.780 |
Why?
| | Tensile Strength | 12 | 2018 | 105 | 0.750 |
Why?
| | Nerve Growth Factors | 4 | 2009 | 74 | 0.740 |
Why?
| | Precision Medicine | 3 | 2023 | 363 | 0.740 |
Why?
| | Photochemistry | 10 | 2009 | 136 | 0.740 |
Why?
| | Cell Communication | 3 | 2019 | 281 | 0.730 |
Why?
| | Skull | 4 | 2014 | 127 | 0.730 |
Why?
| | Lactic Acid | 8 | 2010 | 282 | 0.720 |
Why?
| | Polyethyleneimine | 2 | 2016 | 18 | 0.720 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2022 | 185 | 0.720 |
Why?
| | Cattle | 14 | 2019 | 978 | 0.720 |
Why?
| | Small Molecule Libraries | 2 | 2011 | 80 | 0.720 |
Why?
| | Biology | 1 | 2021 | 83 | 0.720 |
Why?
| | Nanocomposites | 2 | 2009 | 17 | 0.690 |
Why?
| | Extracellular Vesicles | 4 | 2022 | 76 | 0.690 |
Why?
| | Polyphenols | 1 | 2018 | 17 | 0.670 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 179 | 0.660 |
Why?
| | RNAi Therapeutics | 1 | 2018 | 4 | 0.660 |
Why?
| | Biomechanical Phenomena | 15 | 2020 | 683 | 0.650 |
Why?
| | Phosphoproteins | 3 | 2017 | 308 | 0.640 |
Why?
| | Alginates | 3 | 2016 | 51 | 0.640 |
Why?
| | Peptide Hydrolases | 2 | 2018 | 108 | 0.640 |
Why?
| | Azo Compounds | 1 | 2018 | 25 | 0.640 |
Why?
| | Biodegradation, Environmental | 5 | 2012 | 81 | 0.640 |
Why?
| | Fibrinogen | 1 | 2019 | 161 | 0.630 |
Why?
| | Ink | 4 | 2021 | 9 | 0.620 |
Why?
| | Caprolactam | 1 | 2017 | 2 | 0.610 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2017 | 394 | 0.610 |
Why?
| | Musculoskeletal System | 1 | 2018 | 55 | 0.600 |
Why?
| | Organoids | 3 | 2022 | 75 | 0.600 |
Why?
| | Stress, Mechanical | 11 | 2018 | 443 | 0.590 |
Why?
| | Liver Cirrhosis | 2 | 2016 | 245 | 0.590 |
Why?
| | Cell Nucleus | 3 | 2017 | 580 | 0.590 |
Why?
| | Gels | 3 | 2019 | 72 | 0.580 |
Why?
| | Transfection | 3 | 2016 | 888 | 0.580 |
Why?
| | Disease Models, Animal | 19 | 2021 | 3730 | 0.570 |
Why?
| | Models, Cardiovascular | 6 | 2017 | 180 | 0.570 |
Why?
| | Microscopy, Atomic Force | 5 | 2019 | 118 | 0.550 |
Why?
| | Gene Silencing | 1 | 2016 | 177 | 0.550 |
Why?
| | Shear Strength | 2 | 2015 | 55 | 0.550 |
Why?
| | Microscopy, Electron, Scanning | 9 | 2013 | 196 | 0.550 |
Why?
| | Molecular Imprinting | 2 | 2015 | 5 | 0.540 |
Why?
| | Intercellular Signaling Peptides and Proteins | 5 | 2019 | 369 | 0.530 |
Why?
| | Bone Regeneration | 1 | 2015 | 21 | 0.530 |
Why?
| | Surface Properties | 10 | 2018 | 397 | 0.530 |
Why?
| | Chemotaxis | 2 | 2012 | 137 | 0.530 |
Why?
| | Polymethacrylic Acids | 2 | 2013 | 61 | 0.520 |
Why?
| | Genetic Therapy | 1 | 2016 | 267 | 0.510 |
Why?
| | Magnetics | 1 | 2014 | 38 | 0.510 |
Why?
| | RNA Interference | 1 | 2016 | 460 | 0.510 |
Why?
| | Cell Line | 10 | 2018 | 2707 | 0.510 |
Why?
| | Maleimides | 1 | 2014 | 23 | 0.500 |
Why?
| | Tibial Meniscus Injuries | 1 | 2015 | 46 | 0.500 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2014 | 11 | 0.490 |
Why?
| | Bone Marrow Cells | 2 | 2012 | 273 | 0.490 |
Why?
| | Microfluidics | 5 | 2017 | 49 | 0.480 |
Why?
| | Biomedical Engineering | 4 | 2021 | 23 | 0.480 |
Why?
| | Immunosuppressive Agents | 5 | 2004 | 681 | 0.480 |
Why?
| | Compressive Strength | 6 | 2016 | 73 | 0.470 |
Why?
| | Finite Element Analysis | 8 | 2018 | 70 | 0.470 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 167 | 0.460 |
Why?
| | Rats, Wistar | 7 | 2019 | 399 | 0.460 |
Why?
| | Hemodynamics | 5 | 2019 | 1004 | 0.460 |
Why?
| | Nanostructures | 3 | 2015 | 100 | 0.450 |
Why?
| | Molecular Structure | 6 | 2013 | 459 | 0.450 |
Why?
| | Transcription Factors | 4 | 2021 | 1570 | 0.450 |
Why?
| | Extracellular Matrix Proteins | 3 | 2013 | 133 | 0.450 |
Why?
| | Bone Substitutes | 2 | 2003 | 30 | 0.450 |
Why?
| | Proteins | 1 | 2019 | 938 | 0.440 |
Why?
| | Time Factors | 17 | 2019 | 6412 | 0.440 |
Why?
| | Wound Healing | 4 | 2023 | 270 | 0.440 |
Why?
| | Spheroids, Cellular | 3 | 2022 | 56 | 0.440 |
Why?
| | Stem Cell Niche | 1 | 2012 | 43 | 0.430 |
Why?
| | Nerve Regeneration | 2 | 2009 | 53 | 0.420 |
Why?
| | Aorta | 2 | 2011 | 367 | 0.410 |
Why?
| | Calmodulin | 1 | 2011 | 73 | 0.410 |
Why?
| | Myocardial Contraction | 4 | 2018 | 339 | 0.410 |
Why?
| | Computer Simulation | 8 | 2021 | 922 | 0.400 |
Why?
| | Chondroitin Sulfates | 2 | 2009 | 35 | 0.400 |
Why?
| | Fibroblasts | 7 | 2017 | 842 | 0.390 |
Why?
| | Male | 43 | 2019 | 57801 | 0.390 |
Why?
| | Gold | 4 | 2021 | 102 | 0.390 |
Why?
| | Hypertrophy | 1 | 2011 | 121 | 0.390 |
Why?
| | Biophysics | 2 | 2022 | 73 | 0.380 |
Why?
| | Polyesters | 8 | 2009 | 65 | 0.380 |
Why?
| | Mice, Nude | 6 | 2018 | 663 | 0.380 |
Why?
| | Sheep | 7 | 2023 | 764 | 0.380 |
Why?
| | Myocytes, Cardiac | 5 | 2021 | 472 | 0.370 |
Why?
| | Immunotherapy | 2 | 2015 | 493 | 0.370 |
Why?
| | Hexuronic Acids | 3 | 2016 | 30 | 0.360 |
Why?
| | Membranes, Artificial | 1 | 2010 | 70 | 0.360 |
Why?
| | Glucuronic Acid | 3 | 2016 | 33 | 0.360 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2019 | 95 | 0.350 |
Why?
| | Cell- and Tissue-Based Therapy | 3 | 2016 | 54 | 0.340 |
Why?
| | Kidney Diseases | 2 | 2013 | 439 | 0.340 |
Why?
| | Gelatin | 3 | 2021 | 35 | 0.340 |
Why?
| | Biomimetics | 4 | 2021 | 38 | 0.340 |
Why?
| | Ear Auricle | 1 | 2008 | 11 | 0.330 |
Why?
| | Inflammation | 4 | 2016 | 2566 | 0.320 |
Why?
| | Bioprosthesis | 1 | 2008 | 36 | 0.320 |
Why?
| | Transplantation | 1 | 2008 | 26 | 0.320 |
Why?
| | Osteoarthritis | 2 | 2022 | 176 | 0.320 |
Why?
| | Skin | 2 | 2013 | 657 | 0.320 |
Why?
| | Myocardial Ischemia | 3 | 2015 | 251 | 0.310 |
Why?
| | Doxorubicin | 1 | 2009 | 302 | 0.310 |
Why?
| | Neurogenesis | 1 | 2009 | 105 | 0.310 |
Why?
| | Implants, Experimental | 3 | 2013 | 19 | 0.310 |
Why?
| | Bioengineering | 2 | 2019 | 13 | 0.300 |
Why?
| | Molecular Weight | 4 | 2009 | 343 | 0.300 |
Why?
| | Focal Adhesions | 3 | 2018 | 44 | 0.300 |
Why?
| | Ultraviolet Rays | 5 | 2010 | 381 | 0.300 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2018 | 38 | 0.300 |
Why?
| | Mitral Valve Insufficiency | 2 | 2019 | 62 | 0.300 |
Why?
| | Lymphocytes | 2 | 1999 | 347 | 0.300 |
Why?
| | Glioblastoma | 2 | 2021 | 262 | 0.300 |
Why?
| | Waiting Lists | 3 | 2008 | 228 | 0.290 |
Why?
| | Ear Cartilage | 1 | 2006 | 3 | 0.290 |
Why?
| | Electrochemistry | 4 | 2011 | 69 | 0.290 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2018 | 113 | 0.290 |
Why?
| | Prostheses and Implants | 3 | 2019 | 141 | 0.290 |
Why?
| | Viscosity | 3 | 2018 | 83 | 0.280 |
Why?
| | Collagenases | 2 | 2017 | 22 | 0.280 |
Why?
| | Cell Proliferation | 10 | 2019 | 2275 | 0.280 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 907 | 0.280 |
Why?
| | Kinetics | 5 | 2021 | 1624 | 0.270 |
Why?
| | Cell Enlargement | 1 | 2005 | 5 | 0.270 |
Why?
| | Growth Substances | 2 | 2003 | 136 | 0.270 |
Why?
| | Heart | 3 | 2016 | 631 | 0.270 |
Why?
| | Acrylic Resins | 2 | 2016 | 39 | 0.270 |
Why?
| | Drug Compounding | 5 | 2018 | 90 | 0.270 |
Why?
| | Diastole | 2 | 2016 | 145 | 0.270 |
Why?
| | Neurites | 1 | 2005 | 45 | 0.270 |
Why?
| | Durapatite | 3 | 2014 | 33 | 0.260 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 102 | 0.260 |
Why?
| | 3T3 Cells | 3 | 2018 | 141 | 0.260 |
Why?
| | Biomedical Research | 1 | 2011 | 612 | 0.250 |
Why?
| | Flow Cytometry | 3 | 2019 | 1085 | 0.250 |
Why?
| | Magnetic Resonance Imaging | 8 | 2016 | 3174 | 0.250 |
Why?
| | Cells, Immobilized | 3 | 2016 | 22 | 0.250 |
Why?
| | Recovery of Function | 7 | 2019 | 604 | 0.250 |
Why?
| | Calcification, Physiologic | 2 | 2013 | 34 | 0.250 |
Why?
| | Bone Marrow Transplantation | 2 | 2018 | 244 | 0.250 |
Why?
| | Emulsions | 2 | 2022 | 45 | 0.250 |
Why?
| | Elasticity | 4 | 2010 | 193 | 0.240 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 3 | 2015 | 178 | 0.240 |
Why?
| | Orthopedics | 2 | 2023 | 132 | 0.240 |
Why?
| | Proteolysis | 2 | 2015 | 146 | 0.230 |
Why?
| | Immunohistochemistry | 5 | 2014 | 1691 | 0.230 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2023 | 28 | 0.230 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 79 | 0.230 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2022 | 105 | 0.230 |
Why?
| | Anisotropy | 6 | 2016 | 65 | 0.230 |
Why?
| | Cues | 2 | 2022 | 297 | 0.220 |
Why?
| | Glass | 2 | 2016 | 44 | 0.220 |
Why?
| | Butadienes | 1 | 2003 | 33 | 0.220 |
Why?
| | Norbornanes | 2 | 2023 | 13 | 0.220 |
Why?
| | Temperature | 3 | 2011 | 622 | 0.220 |
Why?
| | Technology | 1 | 2023 | 83 | 0.220 |
Why?
| | Alkaline Phosphatase | 4 | 2013 | 157 | 0.210 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2012 | 39 | 0.210 |
Why?
| | Hydrazines | 1 | 2022 | 31 | 0.210 |
Why?
| | Polyhydroxyethyl Methacrylate | 2 | 2013 | 10 | 0.210 |
Why?
| | Hydrazones | 1 | 2022 | 22 | 0.210 |
Why?
| | Recombinant Proteins | 3 | 2018 | 1308 | 0.210 |
Why?
| | Pentoxifylline | 2 | 1999 | 22 | 0.210 |
Why?
| | Mice, Inbred BALB C | 4 | 2015 | 1206 | 0.210 |
Why?
| | Thermodynamics | 3 | 2021 | 392 | 0.210 |
Why?
| | Suspensions | 1 | 2021 | 30 | 0.210 |
Why?
| | Baths | 1 | 2021 | 17 | 0.210 |
Why?
| | Models, Biological | 4 | 2018 | 1715 | 0.200 |
Why?
| | Neostriatum | 1 | 2021 | 30 | 0.200 |
Why?
| | Substantia Nigra | 1 | 2021 | 38 | 0.200 |
Why?
| | Aldehydes | 1 | 2022 | 154 | 0.200 |
Why?
| | Drug Implants | 2 | 2015 | 72 | 0.200 |
Why?
| | Nerve Fibers | 1 | 2021 | 89 | 0.190 |
Why?
| | Drug Liberation | 2 | 2018 | 22 | 0.190 |
Why?
| | Models, Animal | 4 | 2021 | 363 | 0.190 |
Why?
| | Aggrecans | 2 | 2011 | 14 | 0.190 |
Why?
| | Green Fluorescent Proteins | 3 | 2018 | 395 | 0.190 |
Why?
| | Biliary Atresia | 1 | 2023 | 224 | 0.190 |
Why?
| | Fibrosis | 6 | 2020 | 483 | 0.190 |
Why?
| | Collagen Type II | 2 | 2011 | 48 | 0.190 |
Why?
| | Polysaccharides | 1 | 2020 | 78 | 0.190 |
Why?
| | Cyclodextrins | 2 | 2021 | 15 | 0.190 |
Why?
| | Chickens | 2 | 2011 | 185 | 0.190 |
Why?
| | Metal Nanoparticles | 1 | 2021 | 73 | 0.190 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 180 | 0.190 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 65 | 0.190 |
Why?
| | Macrophages | 3 | 2014 | 1324 | 0.190 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 281 | 0.180 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2871 | 0.180 |
Why?
| | Collagen Type I | 2 | 2011 | 114 | 0.180 |
Why?
| | Apoptosis | 2 | 2013 | 2484 | 0.180 |
Why?
| | Cartilage Diseases | 1 | 2020 | 47 | 0.180 |
Why?
| | Disease | 1 | 2021 | 98 | 0.180 |
Why?
| | Acrylates | 2 | 2011 | 47 | 0.180 |
Why?
| | In Vitro Techniques | 3 | 2015 | 1094 | 0.180 |
Why?
| | Acyltransferases | 2 | 2017 | 53 | 0.180 |
Why?
| | Pyrrolidinones | 1 | 1999 | 25 | 0.180 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 412 | 0.180 |
Why?
| | Terminology as Topic | 2 | 2017 | 211 | 0.170 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 86 | 0.170 |
Why?
| | Mitral Valve | 1 | 2019 | 91 | 0.170 |
Why?
| | Anhydrides | 3 | 2005 | 18 | 0.170 |
Why?
| | Gene Expression Regulation | 4 | 2013 | 2445 | 0.170 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 140 | 0.170 |
Why?
| | Chromatin | 1 | 2022 | 441 | 0.170 |
Why?
| | Swine, Miniature | 2 | 2015 | 71 | 0.170 |
Why?
| | Matrix Metalloproteinases | 2 | 2022 | 90 | 0.160 |
Why?
| | Angiogenic Proteins | 1 | 2018 | 21 | 0.160 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2018 | 56 | 0.160 |
Why?
| | Dextran Sulfate | 1 | 2018 | 71 | 0.160 |
Why?
| | Drug Synergism | 2 | 2015 | 339 | 0.160 |
Why?
| | Isomerism | 1 | 2018 | 43 | 0.160 |
Why?
| | Polyglycolic Acid | 4 | 2010 | 44 | 0.160 |
Why?
| | Tacrolimus | 4 | 2004 | 151 | 0.160 |
Why?
| | Connective Tissue Cells | 1 | 2017 | 2 | 0.160 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 384 | 0.160 |
Why?
| | Cell Shape | 2 | 2016 | 57 | 0.160 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2018 | 78 | 0.160 |
Why?
| | Prions | 1 | 2018 | 36 | 0.160 |
Why?
| | Bioreactors | 2 | 2009 | 45 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 1945 | 0.160 |
Why?
| | Time-to-Treatment | 1 | 2019 | 149 | 0.160 |
Why?
| | Serum Albumin, Bovine | 1 | 2018 | 67 | 0.160 |
Why?
| | Treatment Outcome | 7 | 2015 | 9342 | 0.160 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2009 | 508 | 0.160 |
Why?
| | Stromal Cells | 1 | 2018 | 102 | 0.160 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2017 | 83 | 0.150 |
Why?
| | Cyclosporine | 5 | 2004 | 173 | 0.150 |
Why?
| | Molecular Probes | 1 | 2017 | 30 | 0.150 |
Why?
| | Adenocarcinoma | 2 | 2023 | 812 | 0.150 |
Why?
| | Blood Platelets | 1 | 2020 | 369 | 0.150 |
Why?
| | Rats, Nude | 1 | 2017 | 27 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2018 | 62 | 0.150 |
Why?
| | Parkinson Disease | 1 | 2021 | 334 | 0.150 |
Why?
| | Cardiovascular Agents | 1 | 2018 | 126 | 0.150 |
Why?
| | Kidney Transplantation | 6 | 2000 | 585 | 0.150 |
Why?
| | Excitation Contraction Coupling | 1 | 2016 | 18 | 0.150 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2071 | 0.150 |
Why?
| | Pericardium | 1 | 2017 | 50 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 539 | 0.150 |
Why?
| | Cell Aggregation | 1 | 2016 | 24 | 0.140 |
Why?
| | Cardiac Volume | 2 | 2017 | 12 | 0.140 |
Why?
| | Embryonic Stem Cells | 2 | 2007 | 114 | 0.140 |
Why?
| | Hardness | 1 | 2016 | 18 | 0.140 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 195 | 0.140 |
Why?
| | Remission, Spontaneous | 1 | 2016 | 37 | 0.140 |
Why?
| | Bioartificial Organs | 1 | 2016 | 3 | 0.140 |
Why?
| | Heart Conduction System | 1 | 2016 | 81 | 0.140 |
Why?
| | Neurotrophin 3 | 2 | 2006 | 15 | 0.140 |
Why?
| | Adhesiveness | 2 | 2013 | 19 | 0.140 |
Why?
| | Bridged-Ring Compounds | 1 | 2015 | 11 | 0.140 |
Why?
| | Calixarenes | 1 | 2015 | 6 | 0.140 |
Why?
| | Dermis | 1 | 2015 | 29 | 0.140 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1774 | 0.140 |
Why?
| | Fibrin | 1 | 2016 | 60 | 0.140 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 154 | 0.140 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2015 | 46 | 0.130 |
Why?
| | Nanoparticles | 2 | 2010 | 325 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 540 | 0.130 |
Why?
| | Enzyme Therapy | 1 | 2015 | 4 | 0.130 |
Why?
| | Blood Vessel Prosthesis | 2 | 2013 | 115 | 0.130 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2015 | 13 | 0.130 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 139 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 190 | 0.130 |
Why?
| | Phenols | 1 | 2015 | 85 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 371 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2017 | 334 | 0.130 |
Why?
| | Radiography | 2 | 2014 | 861 | 0.130 |
Why?
| | Glycosaminoglycans | 2 | 2012 | 78 | 0.130 |
Why?
| | Ventricular Function | 1 | 2014 | 60 | 0.130 |
Why?
| | Weight-Bearing | 2 | 2013 | 172 | 0.130 |
Why?
| | Fracture Healing | 1 | 2014 | 74 | 0.120 |
Why?
| | Lung | 3 | 2023 | 3664 | 0.120 |
Why?
| | Menisci, Tibial | 1 | 2015 | 59 | 0.120 |
Why?
| | Cardiomyopathies | 2 | 2017 | 299 | 0.120 |
Why?
| | Technology, Pharmaceutical | 1 | 2014 | 18 | 0.120 |
Why?
| | DNA | 3 | 2009 | 1388 | 0.120 |
Why?
| | Imidazoles | 1 | 2015 | 232 | 0.120 |
Why?
| | Bone Remodeling | 1 | 2014 | 64 | 0.120 |
Why?
| | Kidney | 4 | 2016 | 1353 | 0.120 |
Why?
| | Graft Survival | 5 | 2018 | 504 | 0.120 |
Why?
| | Injections, Intradermal | 1 | 2013 | 11 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2436 | 0.120 |
Why?
| | Neuregulin-1 | 1 | 2014 | 43 | 0.120 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 101 | 0.120 |
Why?
| | Neovascularization, Pathologic | 1 | 2016 | 287 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 359 | 0.120 |
Why?
| | Prosthesis Design | 1 | 2015 | 285 | 0.120 |
Why?
| | Solubility | 1 | 2014 | 235 | 0.120 |
Why?
| | Glucocorticoids | 1 | 1998 | 545 | 0.120 |
Why?
| | Vinculin | 1 | 2013 | 11 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2016 | 276 | 0.120 |
Why?
| | Molecular Mimicry | 1 | 2013 | 40 | 0.110 |
Why?
| | Osseointegration | 1 | 2013 | 37 | 0.110 |
Why?
| | Echocardiography | 2 | 2016 | 556 | 0.110 |
Why?
| | Graft Rejection | 5 | 2000 | 555 | 0.110 |
Why?
| | Biological Products | 1 | 2016 | 170 | 0.110 |
Why?
| | Fibrocartilage | 1 | 2012 | 7 | 0.110 |
Why?
| | Coculture Techniques | 3 | 2019 | 208 | 0.110 |
Why?
| | Receptors, Notch | 1 | 2013 | 85 | 0.110 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 164 | 0.110 |
Why?
| | PPAR gamma | 1 | 2013 | 188 | 0.110 |
Why?
| | Axons | 2 | 2021 | 185 | 0.110 |
Why?
| | Cardiac Output | 2 | 2011 | 147 | 0.110 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 462 | 0.110 |
Why?
| | Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2011 | 2 | 0.110 |
Why?
| | Static Electricity | 1 | 2012 | 121 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2012 | 527 | 0.110 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2009 | 76 | 0.100 |
Why?
| | Methylmethacrylates | 1 | 2011 | 4 | 0.100 |
Why?
| | P-Selectin | 1 | 2011 | 26 | 0.100 |
Why?
| | Transition Temperature | 1 | 2011 | 28 | 0.100 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 217 | 0.100 |
Why?
| | Myocardial Reperfusion | 1 | 2011 | 53 | 0.100 |
Why?
| | Cell Polarity | 1 | 2012 | 133 | 0.100 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2011 | 21 | 0.100 |
Why?
| | Acrylamides | 1 | 2011 | 42 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 465 | 0.100 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 86 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 67 | 0.100 |
Why?
| | A Kinase Anchor Proteins | 1 | 2011 | 72 | 0.100 |
Why?
| | Protein Engineering | 1 | 2011 | 107 | 0.100 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2011 | 53 | 0.100 |
Why?
| | Microvessels | 1 | 2011 | 77 | 0.090 |
Why?
| | Polymerization | 1 | 2011 | 129 | 0.090 |
Why?
| | Micelles | 1 | 2010 | 34 | 0.090 |
Why?
| | Glycolates | 2 | 2010 | 3 | 0.090 |
Why?
| | Models, Chemical | 2 | 2002 | 274 | 0.090 |
Why?
| | Pressure | 1 | 2010 | 226 | 0.090 |
Why?
| | Cell Division | 2 | 2004 | 776 | 0.090 |
Why?
| | Molecular Conformation | 1 | 2010 | 146 | 0.090 |
Why?
| | Macromolecular Substances | 1 | 2010 | 201 | 0.090 |
Why?
| | Chitosan | 2 | 2007 | 30 | 0.090 |
Why?
| | Coronary Vessels | 1 | 2011 | 233 | 0.090 |
Why?
| | Photolysis | 1 | 2010 | 80 | 0.090 |
Why?
| | Microscopy | 1 | 2010 | 125 | 0.090 |
Why?
| | Ethylene Glycols | 1 | 2009 | 15 | 0.090 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 122 | 0.090 |
Why?
| | Adult | 11 | 2021 | 31512 | 0.090 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2009 | 17 | 0.090 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2009 | 10 | 0.090 |
Why?
| | Absorption | 1 | 2009 | 56 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 1798 | 0.090 |
Why?
| | Liposomes | 1 | 2010 | 151 | 0.080 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2009 | 75 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2016 | 709 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2851 | 0.080 |
Why?
| | Lactates | 2 | 2005 | 87 | 0.080 |
Why?
| | Methylprednisolone | 2 | 1999 | 84 | 0.080 |
Why?
| | Metals | 1 | 2009 | 111 | 0.080 |
Why?
| | Surface-Active Agents | 1 | 2009 | 81 | 0.080 |
Why?
| | Peripheral Nerves | 1 | 2009 | 65 | 0.080 |
Why?
| | Mesoderm | 1 | 2009 | 141 | 0.080 |
Why?
| | Pyrroles | 1 | 2009 | 191 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 589 | 0.080 |
Why?
| | Sheep, Domestic | 2 | 2019 | 32 | 0.080 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2008 | 8 | 0.080 |
Why?
| | Asia | 1 | 2008 | 54 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 814 | 0.080 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 314 | 0.080 |
Why?
| | Hydrolysis | 1 | 2008 | 176 | 0.080 |
Why?
| | Propylene Glycols | 1 | 2007 | 27 | 0.080 |
Why?
| | Immunoenzyme Techniques | 1 | 2008 | 195 | 0.080 |
Why?
| | Organ Specificity | 1 | 2008 | 278 | 0.080 |
Why?
| | Equipment Design | 1 | 2009 | 519 | 0.080 |
Why?
| | Geography | 1 | 2008 | 190 | 0.080 |
Why?
| | Neurons | 3 | 2021 | 1345 | 0.080 |
Why?
| | Travel | 1 | 2008 | 116 | 0.070 |
Why?
| | Ventricular Pressure | 2 | 2018 | 41 | 0.070 |
Why?
| | Muscle Cells | 1 | 2007 | 42 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2013 | 1055 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2016 | 164 | 0.070 |
Why?
| | Hot Temperature | 1 | 2009 | 334 | 0.070 |
Why?
| | Ligands | 2 | 2021 | 567 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 255 | 0.070 |
Why?
| | Cell Count | 3 | 2013 | 315 | 0.070 |
Why?
| | Tissue and Organ Procurement | 2 | 2008 | 248 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 509 | 0.070 |
Why?
| | Lipids | 1 | 2010 | 607 | 0.070 |
Why?
| | Cardiac Surgical Procedures | 1 | 2010 | 461 | 0.070 |
Why?
| | Adipates | 1 | 2005 | 2 | 0.070 |
Why?
| | Decanoic Acids | 1 | 2005 | 7 | 0.070 |
Why?
| | Ethylamines | 1 | 2005 | 4 | 0.070 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 2005 | 8 | 0.070 |
Why?
| | Erythroblasts | 1 | 2005 | 12 | 0.070 |
Why?
| | Cohort Studies | 2 | 2010 | 5116 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2014 | 806 | 0.070 |
Why?
| | Muscles | 2 | 2001 | 333 | 0.070 |
Why?
| | Polyanhydrides | 1 | 2005 | 2 | 0.070 |
Why?
| | Carbohydrate Sequence | 1 | 2005 | 23 | 0.070 |
Why?
| | HEK293 Cells | 2 | 2018 | 625 | 0.060 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 117 | 0.060 |
Why?
| | Transcriptome | 2 | 2021 | 756 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2025 | 0.060 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 173 | 0.060 |
Why?
| | Tissue Donors | 2 | 1997 | 336 | 0.060 |
Why?
| | Perfusion | 1 | 2023 | 153 | 0.060 |
Why?
| | Cell Separation | 1 | 2004 | 296 | 0.060 |
Why?
| | Bilirubin | 1 | 2023 | 95 | 0.060 |
Why?
| | Spinal Cord Injuries | 1 | 2006 | 184 | 0.060 |
Why?
| | Biosensing Techniques | 1 | 2004 | 107 | 0.060 |
Why?
| | Retina | 1 | 2005 | 278 | 0.060 |
Why?
| | Chromatography, Gel | 1 | 2003 | 133 | 0.060 |
Why?
| | Connective Tissue | 1 | 2022 | 37 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 195 | 0.050 |
Why?
| | Theranostic Nanomedicine | 1 | 2022 | 8 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 183 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 17 | 0.050 |
Why?
| | Liver Transplantation | 3 | 1995 | 847 | 0.050 |
Why?
| | Cholic Acid | 1 | 2021 | 4 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 522 | 0.050 |
Why?
| | Aspergillus fumigatus | 1 | 2001 | 21 | 0.050 |
Why?
| | Tendons | 1 | 2023 | 137 | 0.050 |
Why?
| | Photochemotherapy | 1 | 2001 | 29 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 565 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 181 | 0.050 |
Why?
| | Chlorobenzenes | 1 | 2001 | 8 | 0.050 |
Why?
| | Succinimides | 1 | 2001 | 17 | 0.050 |
Why?
| | Nuclear Envelope | 1 | 2021 | 21 | 0.050 |
Why?
| | Polystyrenes | 1 | 2001 | 33 | 0.050 |
Why?
| | Cell Engineering | 1 | 2020 | 6 | 0.050 |
Why?
| | Fluorescent Dyes | 2 | 2015 | 316 | 0.050 |
Why?
| | Optical Imaging | 1 | 2021 | 56 | 0.050 |
Why?
| | Plasmapheresis | 1 | 2000 | 23 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 454 | 0.050 |
Why?
| | X-Ray Microtomography | 1 | 2020 | 79 | 0.050 |
Why?
| | Adsorption | 1 | 2001 | 129 | 0.050 |
Why?
| | Epigenomics | 1 | 2021 | 107 | 0.050 |
Why?
| | Kidney Glomerulus | 2 | 1998 | 133 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 4908 | 0.050 |
Why?
| | Cryopreservation | 1 | 2021 | 99 | 0.050 |
Why?
| | Registries | 1 | 2008 | 1810 | 0.050 |
Why?
| | Fibronectins | 1 | 2020 | 114 | 0.050 |
Why?
| | Rolipram | 1 | 1999 | 3 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2004 | 1067 | 0.040 |
Why?
| | Tritium | 1 | 1999 | 70 | 0.040 |
Why?
| | Thymidine | 1 | 1999 | 62 | 0.040 |
Why?
| | Neural Pathways | 1 | 2021 | 277 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 510 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2000 | 128 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 213 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 187 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 690 | 0.040 |
Why?
| | Nephrectomy | 1 | 2000 | 162 | 0.040 |
Why?
| | Middle Aged | 8 | 2018 | 27617 | 0.040 |
Why?
| | Cathelicidins | 1 | 2018 | 39 | 0.040 |
Why?
| | Biopsy | 3 | 2016 | 1079 | 0.040 |
Why?
| | beta Karyopherins | 1 | 2018 | 8 | 0.040 |
Why?
| | RNA-Binding Protein EWS | 1 | 2018 | 16 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2019 | 220 | 0.040 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2018 | 15 | 0.040 |
Why?
| | Karyopherins | 1 | 2018 | 17 | 0.040 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 1998 | 39 | 0.040 |
Why?
| | Prednisolone | 1 | 1998 | 76 | 0.040 |
Why?
| | Cell Size | 1 | 2018 | 86 | 0.040 |
Why?
| | Paracrine Communication | 1 | 2018 | 57 | 0.040 |
Why?
| | Systole | 1 | 2018 | 168 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2018 | 146 | 0.040 |
Why?
| | Phenotype | 3 | 2014 | 3003 | 0.040 |
Why?
| | Living Donors | 1 | 2000 | 319 | 0.040 |
Why?
| | Biological Transport, Active | 1 | 2017 | 73 | 0.040 |
Why?
| | Actomyosin | 1 | 2017 | 10 | 0.040 |
Why?
| | Integrins | 1 | 2018 | 82 | 0.040 |
Why?
| | Stress Fibers | 1 | 2017 | 18 | 0.040 |
Why?
| | Cytoplasm | 1 | 2018 | 269 | 0.040 |
Why?
| | Histones | 1 | 2022 | 552 | 0.040 |
Why?
| | Aged | 4 | 2018 | 19657 | 0.040 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 64 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 709 | 0.040 |
Why?
| | Health Care Rationing | 1 | 1997 | 48 | 0.040 |
Why?
| | Protein Domains | 1 | 2018 | 212 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 2018 | 174 | 0.040 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 99 | 0.040 |
Why?
| | HeLa Cells | 1 | 2018 | 583 | 0.040 |
Why?
| | Sus scrofa | 1 | 2016 | 48 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 200 | 0.040 |
Why?
| | Lipocalin-2 | 1 | 2016 | 64 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 502 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 204 | 0.030 |
Why?
| | Laparoscopy | 1 | 2000 | 417 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1999 | 736 | 0.030 |
Why?
| | Acidosis, Renal Tubular | 1 | 1995 | 7 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 900 | 0.030 |
Why?
| | Databases, Factual | 1 | 2001 | 1231 | 0.030 |
Why?
| | Oxazines | 1 | 2015 | 25 | 0.030 |
Why?
| | Capsules | 1 | 2015 | 35 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2015 | 185 | 0.030 |
Why?
| | Dextrans | 1 | 2015 | 74 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2014 | 33 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 152 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1998 | 1293 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 95 | 0.030 |
Why?
| | Trans-Activators | 1 | 2017 | 373 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 404 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 270 | 0.030 |
Why?
| | Kidney Tubules, Proximal | 1 | 1995 | 131 | 0.030 |
Why?
| | Venous Cutdown | 1 | 1994 | 1 | 0.030 |
Why?
| | Homeostasis | 1 | 2018 | 594 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 486 | 0.030 |
Why?
| | Female | 10 | 2018 | 61565 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2015 | 536 | 0.030 |
Why?
| | Stroke Volume | 1 | 2016 | 513 | 0.030 |
Why?
| | Jagged-1 Protein | 1 | 2013 | 25 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2013 | 30 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2013 | 12 | 0.030 |
Why?
| | Catheters, Indwelling | 1 | 1994 | 81 | 0.030 |
Why?
| | Random Allocation | 1 | 2014 | 344 | 0.030 |
Why?
| | Attitude to Health | 1 | 1997 | 410 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 93 | 0.030 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2016 | 541 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1323 | 0.030 |
Why?
| | Lactones | 1 | 2012 | 57 | 0.030 |
Why?
| | Creatinine | 3 | 2000 | 491 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2016 | 688 | 0.030 |
Why?
| | L-Selectin | 1 | 2011 | 25 | 0.030 |
Why?
| | Blood Pressure | 2 | 2016 | 1664 | 0.030 |
Why?
| | Diffusion | 1 | 2012 | 122 | 0.030 |
Why?
| | Fluorescence | 1 | 2012 | 159 | 0.030 |
Why?
| | United States | 1 | 2008 | 12555 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 219 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1597 | 0.030 |
Why?
| | Biomarkers | 1 | 2022 | 3588 | 0.020 |
Why?
| | Cyclosporins | 1 | 1991 | 60 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2011 | 121 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2011 | 191 | 0.020 |
Why?
| | Postoperative Complications | 2 | 2000 | 2235 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1346 | 0.020 |
Why?
| | Hepatitis B | 1 | 1991 | 52 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2011 | 278 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2490 | 0.020 |
Why?
| | Surgical Mesh | 1 | 2010 | 41 | 0.020 |
Why?
| | Morphogenesis | 1 | 2011 | 167 | 0.020 |
Why?
| | Electric Conductivity | 1 | 2009 | 91 | 0.020 |
Why?
| | Fluorescein | 1 | 2009 | 27 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 228 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2009 | 59 | 0.020 |
Why?
| | Sepharose | 1 | 2009 | 33 | 0.020 |
Why?
| | Fetal Blood | 1 | 2011 | 272 | 0.020 |
Why?
| | Histocompatibility Testing | 2 | 2000 | 123 | 0.020 |
Why?
| | Biological Assay | 1 | 2009 | 122 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2011 | 359 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2011 | 374 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3457 | 0.020 |
Why?
| | Pregnancy Complications, Infectious | 1 | 1991 | 296 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 163 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 827 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 31 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2007 | 157 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2006 | 96 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 87 | 0.020 |
Why?
| | Child | 2 | 2023 | 19129 | 0.020 |
Why?
| | Hypertension | 1 | 1995 | 1203 | 0.020 |
Why?
| | Acute Disease | 2 | 2000 | 940 | 0.020 |
Why?
| | Neuroglia | 1 | 2006 | 157 | 0.020 |
Why?
| | Actins | 1 | 2007 | 404 | 0.020 |
Why?
| | Body Fluids | 1 | 2005 | 62 | 0.020 |
Why?
| | Laminin | 1 | 2004 | 68 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2004 | 200 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2004 | 220 | 0.010 |
Why?
| | Particle Size | 1 | 2005 | 345 | 0.010 |
Why?
| | Spinal Cord | 1 | 2006 | 367 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 2874 | 0.010 |
Why?
| | Motor Activity | 1 | 2006 | 660 | 0.010 |
Why?
| | Sequence Tagged Sites | 1 | 2001 | 4 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2001 | 20 | 0.010 |
Why?
| | Information Services | 1 | 2001 | 46 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2000 | 184 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 702 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 546 | 0.010 |
Why?
| | Antibody Formation | 1 | 2000 | 276 | 0.010 |
Why?
| | Cytokines | 1 | 2006 | 1900 | 0.010 |
Why?
| | Antibodies | 1 | 2000 | 392 | 0.010 |
Why?
| | Follow-Up Studies | 2 | 1998 | 4596 | 0.010 |
Why?
| | Bone and Bones | 1 | 2000 | 289 | 0.010 |
Why?
| | Thrombosis | 1 | 2000 | 309 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1267 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 182 | 0.010 |
Why?
| | Lymphoproliferative Disorders | 1 | 1996 | 46 | 0.010 |
Why?
| | Internet | 1 | 2001 | 633 | 0.010 |
Why?
| | Telephone | 1 | 1997 | 152 | 0.010 |
Why?
| | Drug Resistance | 1 | 1996 | 167 | 0.010 |
Why?
| | Diarrhea, Infantile | 1 | 1995 | 7 | 0.010 |
Why?
| | Cadaver | 1 | 1997 | 327 | 0.010 |
Why?
| | Blood Urea Nitrogen | 1 | 1995 | 59 | 0.010 |
Why?
| | Bicarbonates | 1 | 1995 | 44 | 0.010 |
Why?
| | Reperfusion | 1 | 1995 | 43 | 0.010 |
Why?
| | Atrophy | 1 | 1995 | 164 | 0.010 |
Why?
| | Interviews as Topic | 1 | 1997 | 599 | 0.010 |
Why?
| | Fluid Therapy | 1 | 1995 | 131 | 0.010 |
Why?
| | Axillary Vein | 1 | 1994 | 2 | 0.010 |
Why?
| | Oxygenators | 1 | 1994 | 4 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1994 | 13 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 1996 | 187 | 0.010 |
Why?
| | Subclavian Vein | 1 | 1994 | 22 | 0.010 |
Why?
| | Kidney Tubules | 1 | 1995 | 128 | 0.010 |
Why?
| | Femoral Vein | 1 | 1994 | 29 | 0.010 |
Why?
| | Hepatic Artery | 1 | 1994 | 55 | 0.010 |
Why?
| | Triazines | 1 | 1974 | 39 | 0.010 |
Why?
| | Jugular Veins | 1 | 1994 | 47 | 0.010 |
Why?
| | Elbow | 1 | 1994 | 54 | 0.010 |
Why?
| | Veins | 1 | 1994 | 60 | 0.010 |
Why?
| | Incidence | 1 | 2000 | 2424 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1994 | 55 | 0.010 |
Why?
| | Portal Vein | 1 | 1994 | 90 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 756 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 676 | 0.010 |
Why?
| | Catheterization, Central Venous | 1 | 1994 | 95 | 0.010 |
Why?
| | Health Status | 1 | 1997 | 726 | 0.010 |
Why?
| | Transplantation, Isogeneic | 1 | 1991 | 17 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1991 | 46 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1991 | 49 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 1991 | 53 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 1991 | 87 | 0.010 |
Why?
| | Blood Transfusion | 1 | 1994 | 306 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2000 | 12978 | 0.010 |
Why?
| | Hindlimb | 1 | 1991 | 137 | 0.010 |
Why?
| | Major Histocompatibility Complex | 1 | 1991 | 220 | 0.010 |
Why?
| | Heart Rate | 1 | 1994 | 729 | 0.010 |
Why?
| | Kidney Neoplasms | 1 | 1974 | 334 | 0.010 |
Why?
| | Anesthesia | 1 | 1991 | 120 | 0.010 |
Why?
| | Prevalence | 1 | 1995 | 2326 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 1995 | 2513 | 0.010 |
Why?
| | Risk Factors | 1 | 2000 | 9000 | 0.000 |
Why?
| | Quality of Life | 1 | 1997 | 2366 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1974 | 1974 | 0.000 |
Why?
| | Infant | 1 | 1995 | 8293 | 0.000 |
Why?
| | Adolescent | 1 | 1998 | 18480 | 0.000 |
Why?
| | Pregnancy | 1 | 1991 | 5691 | 0.000 |
Why?
| | Dimethylamines | 1 | 1974 | 7 | 0.000 |
Why?
| | Neoplasm Transplantation | 1 | 1974 | 245 | 0.000 |
Why?
| | Transplantation, Homologous | 1 | 1974 | 415 | 0.000 |
Why?
|
|
Burdick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|